| Date Filed | Type | Description |
| 07/12/2023 |
4
| Wasman Jane (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
4
| Wasman Jane (Director) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Granted 22,321 shares
@ $0 |
|
| 09/20/2022 |
4
| Wasman Jane (Director) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Granted 12,820 shares
@ $0
Granted 32,042 options to buy
@ $1.95, valued at
$62.5k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Wasman Jane (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 1,900 shares
@ $0
Granted 7,125 options to buy
@ $5.34, valued at
$38k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2020 |
4
| Wasman Jane (Director) has filed a Form 4 on ATHERSYS, INC / NEW|
Txns:
| Granted 100,000 options to buy
@ $1.88, valued at
$188k
|
|
| 11/16/2020 |
3
| Wasman Jane (Director) has filed a Form 3 on ATHERSYS, INC / NEW |
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2019 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 2,227 shares
@ $1.5953, valued at
$3.6k
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2019 |
4
| Wasman Jane (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 13,750 options to buy
@ $2.02, valued at
$27.8k
|
|
| 04/03/2019 |
4
| Wasman Jane (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 80,000 options to buy
@ $2.42, valued at
$193.6k
|
|
| 04/03/2019 |
3
| Wasman Jane (Director) has filed a Form 3 on RIGEL PHARMACEUTICALS INC |
| 03/18/2019 |
4
| Wasman Jane (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.38, valued at
$34.5k
|
|
| 03/12/2019 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 12,813 shares
@ $0
Granted 21,355 options to buy
@ $13.51, valued at
$288.5k
|
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2018 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 12/06/2018 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 3,067 shares
@ $20.5241, valued at
$62.9k
|
|
| 11/07/2018 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 955 shares
@ $20.28, valued at
$19.4k
|
|
| 09/12/2018 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 2,500 shares
@ $0 |
|
| 06/13/2018 |
4
| Wasman Jane (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 5,500 options to buy
@ $5.23, valued at
$28.8k
|
|
| 03/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2018 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 2,470 shares
@ $25.65, valued at
$63.4k
|
|
| 03/07/2018 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 2,274 shares
@ $25.95, valued at
$59k
Exercised 2,980 options to buy
@ $19.81, valued at
$59k
|
|
| 02/26/2018 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 6,463 shares
@ $0 |
|
| 01/23/2018 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 34,170 shares
@ $27.5768, valued at
$942.3k
Sold 350 shares
@ $28.6286, valued at
$10k
Exercised 34,520 options to buy
@ $19.81, valued at
$683.8k
|
|
| 12/29/2017 |
3
| Wasman Jane (Director) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 12/05/2017 |
4
| Wasman Jane (President, Intl and GC) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 4,564 shares
@ $20.522, valued at
$93.7k
|
|
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|